We suggest that carriage of non-O blood groups may elevate risk of ovarian cancer and can play a role in its development.
No takes yet. Share an insight, caveat, or question.
Yuzhalin et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: